Snapdragon Chemistry Names Andy Miles Director of Business Development

08.02.2021

Waltham, MA – August 2, 2021 – Snapdragon Chemistry today announced the hiring of Andy Miles as the company’s first ever Director of Business Development. In that position, Miles will manage sales for all Snapdragon services including projects headed to the new cGMP facility, opening in 1Q 2022 down the street from the company’s Waltham, Massachusetts headquarters.

“Andy brings a breadth and depth of selling and marketing GMP manufacturing services,” said Snapdragon President and CEO Matthew Bio “He is known throughout the industry for collaborating with clients to understand their needs and then working with them closely to provide services that match their unique circumstances. We couldn’t be more pleased to bring Andy onboard as we approach our next growth inflexion point.”

Miles brings more than 20 years of experience in the pharmaceutical and biotech industries to Snapdragon. Over that time, he’s exhibited a proven track record of merging the scientific and business needs of the industry to effectively satisfy all parties. His business development knowledge includes an in-depth understanding of organic synthesis, chromatography, API process development, GMP manufacturing and drug development.

About Snapdragon Chemistry
Snapdragon Chemistry specializes in active pharmaceutical ingredient (API) batch and continuous flow process development, utilizing state-of-the-art automation technology and proprietary equipment to solve complex process and analytical development challenges. With R&D and manufacturing headquartered in Waltham, Massachusetts, Snapdragon’s 70+ employees come with strong ties to the local scientific community, with 31 PhD scientists on staff. For more information, please contact info@snapdragonchemistry.com.